Adjarai, Al-furqan .
HRN: 26-69-21 Sex: MalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/23/2026
CEFUROXIME 750MG (VIAL)
06/23/2026
06/29/2026
IV
230mg
Q8
Acute Bacterial Infection
Checking Initial Appropriateness
06/26/2026
CEFTRIAXONE 1G (VIAL)
06/26/2026
07/02/2026
IV
690mg
OD
UTI
Checking Initial Appropriateness
06/27/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
06/27/2026
07/04/2026
IV
690mg
Q6h
Uti
Checking Initial Appropriateness